CSPC Pharmaceutical Statistics Share Statistics CSPC Pharmaceutical has 3.04B
shares outstanding. The number of shares has increased by -2.44%
in one year.
Shares Outstanding 3.04B Shares Change (YoY) -2.44% Shares Change (QoQ) 0.46% Owned by Institutions (%) n/a Shares Floating 2.9B Failed to Deliver (FTD) Shares 1,077 FTD / Avg. Volume 42.79%
Short Selling Information The latest short interest is 10, so 0% of the outstanding
shares have been sold short.
Short Interest 10 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 12.43 and the forward
PE ratio is null.
CSPC Pharmaceutical's PEG ratio is
-0.39.
PE Ratio 12.43 Forward PE n/a PS Ratio 1.85 Forward PS 0.1 PB Ratio 1.67 P/FCF Ratio 28.99 PEG Ratio -0.39
Financial Ratio History Enterprise Valuation CSPC Pharmaceutical has an Enterprise Value (EV) of 208.91B.
EV / Sales 7.2 EV / EBITDA 30.01 EV / EBIT 46.07 EV / FCF 112.57
Financial Position The company has a current ratio of 2.27,
with a Debt / Equity ratio of 0.02.
Current Ratio 2.27 Quick Ratio 1.95 Debt / Equity 0.02 Debt / EBITDA 0.07 Debt / FCF 0.27 Interest Coverage 122.87
Financial Efficiency Return on Equity is 13.41% and Return on Invested Capital is 11.85%.
Return on Equity 13.41% Return on Assets 9.75% Return on Invested Capital 11.85% Revenue Per Employee $1.36M Profits Per Employee $202.24K Employee Count 21,400 Asset Turnover 0.65 Inventory Turnover 2.78
Taxes Income Tax 1.24B Effective Tax Rate 22.23%
Stock Price Statistics The stock price has increased by 80.68% in the
last 52 weeks. The beta is 0.71, so CSPC Pharmaceutical's
price volatility has been higher than the market average.
Beta 0.71 52-Week Price Change 80.68% 50-Day Moving Average 4.33 200-Day Moving Average 3.04 Relative Strength Index (RSI) 62.33 Average Volume (20 Days) 2,517
Income Statement In the last 12 months, CSPC Pharmaceutical had revenue of 29.01B
and earned 4.33B
in profits. Earnings per share was 1.48.
Revenue 29.01B Gross Profit 20.3B Operating Income 5.37B Net Income 4.33B EBITDA 6.96B EBIT 5.62B Earnings Per Share (EPS) 1.48
Full Income Statement Balance Sheet The company has 6.78B in cash and 507.33M in
debt, giving a net cash position of 6.27B.
Cash & Cash Equivalents 6.78B Total Debt 507.33M Net Cash 6.27B Retained Earnings 23.34B Total Assets 44.39B Working Capital 12.25B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 4.53B
and capital expenditures -2.68B, giving a free cash flow of 1.86B.
Operating Cash Flow 4.53B Capital Expenditures -2.68B Free Cash Flow 1.86B FCF Per Share 0.63
Full Cash Flow Statement Margins Gross margin is 69.97%, with operating and profit margins of 18.5% and 14.92%.
Gross Margin 69.97% Operating Margin 18.5% Pretax Margin 19.23% Profit Margin 14.92% EBITDA Margin 24% EBIT Margin 18.5% FCF Margin 6.4%
Dividends & Yields CSPCY pays an annual dividend of $0.13,
which amounts to a dividend yield of 3.52%.
Dividend Per Share $0.13 Dividend Yield 3.52% Dividend Growth (YoY) -28.58% Payout Ratio 66.71% Earnings Yield 8.05% FCF Yield 0.86%
Dividend Details Analyst Forecast Currently there are no analyst rating for CSPCY.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $7.4 Lynch Upside 38.84% Graham Number 4.78 Graham Upside -10.32%
Stock Splits The last stock split was on Dec 10, 2020. It was a
forward
split with a ratio of 8:5.
Last Split Date Dec 10, 2020 Split Type forward Split Ratio 8:5
Scores Altman Z-Score 3.41 Piotroski F-Score 8
